About UrSure
UrSure is a company based in Boston (United States) founded in 2015 was acquired by OraSure in May 2020. UrSure operates in a competitive market with competitors including Souzhou Ribo Life Science, PathoQuest, Quantalife, Chembio and Senzo, among others.
- Headquarter Boston, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
OraSure Technologies
& 1 more
-
Employee Count
Employee Count
-
Acquired by
OraSure
(May 29, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of UrSure
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2017 | Amount | Grant - UrSure | Valuation |
investors |
Investors in UrSure
UrSure has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include OraSure Technologies and MassChallenge.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage entrepreneurs are accelerated through MassChallenge's program.
|
Founded Year | Domain | Location | |
|
Point-of-care diagnostic devices for oral fluid specimens are provided.
|
Founded Year | Domain | Location |
Investments & Acquisitions by UrSure
Financial Statements - UrSure
Ursure Comparisons
Competitors of UrSure
UrSure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Souzhou Ribo Life Science, PathoQuest, Quantalife, Chembio and Senzo, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Nucleic acid drugs are developed via RNA interference technology.
|
|
| domain | founded_year | HQ Location |
Next-generation sequencing is provided for microbiology testing applications.
|
|
| domain | founded_year | HQ Location |
Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease.
|
|
| domain | founded_year | HQ Location |
Proprietary immunoassay platform is utilized for infectious disease diagnostics.
|
|
| domain | founded_year | HQ Location |
Point-of-care diagnostic devices for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Biopreservation platform for mammalian cells and biologics is developed.
|
Latest news on Ursure
Frequently Asked Questions about UrSure
UrSure was founded in 2015 and raised its 1st funding round 2 years after it was founded.
UrSure is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
UrSure was founded in 2015 in Boston, United States, within the health diagnostics sector. A non-invasive mass spectrometry-based urine test is provided to assess adherence to HIV preventive medication (PrEP). Two variants of the test are offered, one suited for centralized laboratories and another for decentralized testing environments. This approach allows healthcare providers to prioritize monitoring of high-risk patients based on PrEP usage patterns.
UrSure's top competitors include Souzhou Ribo Life Science, Chembio and Quantalife.
UrSure has 2 investors. Key investors include OraSure Technologies, and MassChallenge.